NO20022057L - Fremgangsmåte og sammensetning for å behandle lungesykdommer - Google Patents

Fremgangsmåte og sammensetning for å behandle lungesykdommer

Info

Publication number
NO20022057L
NO20022057L NO20022057A NO20022057A NO20022057L NO 20022057 L NO20022057 L NO 20022057L NO 20022057 A NO20022057 A NO 20022057A NO 20022057 A NO20022057 A NO 20022057A NO 20022057 L NO20022057 L NO 20022057L
Authority
NO
Norway
Prior art keywords
composition
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
NO20022057A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022057D0 (no
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20022057D0 publication Critical patent/NO20022057D0/no
Publication of NO20022057L publication Critical patent/NO20022057L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022057A 1999-11-02 2002-04-30 Fremgangsmåte og sammensetning for å behandle lungesykdommer NO20022057L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
NO20022057D0 NO20022057D0 (no) 2002-04-30
NO20022057L true NO20022057L (no) 2002-06-27

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022057A NO20022057L (no) 1999-11-02 2002-04-30 Fremgangsmåte og sammensetning for å behandle lungesykdommer

Country Status (29)

Country Link
EP (1) EP1225866A4 (sk)
JP (1) JP2003513028A (sk)
KR (1) KR20020057988A (sk)
CN (1) CN1387404A (sk)
AP (1) AP2002002496A0 (sk)
AR (1) AR029189A1 (sk)
AU (1) AU1357501A (sk)
BG (1) BG106748A (sk)
BR (1) BR0015270A (sk)
CA (1) CA2388333A1 (sk)
CO (1) CO5261512A1 (sk)
CZ (1) CZ20021512A3 (sk)
DZ (1) DZ3225A1 (sk)
EA (1) EA200200518A1 (sk)
EC (1) ECSP003747A (sk)
HK (1) HK1049107A1 (sk)
HU (1) HUP0203152A3 (sk)
IL (1) IL149367A0 (sk)
MA (1) MA26841A1 (sk)
MX (1) MXPA02004350A (sk)
NO (1) NO20022057L (sk)
OA (1) OA12076A (sk)
PE (1) PE20011005A1 (sk)
PL (1) PL355261A1 (sk)
SK (1) SK7592002A3 (sk)
TR (1) TR200201211T2 (sk)
TW (1) TWI242431B (sk)
WO (1) WO2001032127A2 (sk)
ZA (1) ZA200203435B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
CZ20021512A3 (cs) 2003-04-16
HUP0203152A3 (en) 2004-06-28
DZ3225A1 (fr) 2001-05-10
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
ECSP003747A (es) 2002-05-23
CO5261512A1 (es) 2003-03-31
WO2001032127A3 (en) 2001-12-06
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
PL355261A1 (en) 2004-04-05
CN1387404A (zh) 2002-12-25
IL149367A0 (en) 2002-11-10
WO2001032127A2 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
CA2388333A1 (en) 2001-05-10
AR029189A1 (es) 2003-06-18
AU1357501A (en) 2001-05-14
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (no) 2002-04-30
EP1225866A4 (en) 2004-04-21
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
HK1049107A1 (zh) 2003-05-02

Similar Documents

Publication Publication Date Title
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO995164D0 (no) Preparat for å kontrollere skadelige bioorganismer og fremgangsmåte for å kontrollere skadelige bioorganismer ved anvendelse derav
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20012344D0 (no) Sammensetninger og fremgangsmåter for å kontrollere plantepester
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20013193L (no) Fremgangsmåte og kit for å ekstrahere prionprotein
NO20025627L (no) Fremgangsmåter og sammensetninger for å behandle hepatitt C virus
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
NO20022057D0 (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20013752D0 (no) Beregningssystem og fremgangsmåte for å modellere hjertet
NO20005763L (no) DHEA-sammensetning og fremgangsmåte
IL150963A0 (en) Method and compositions for treating an inflammatory disease
NO20014569L (no) Fremgangsmåte og sammensetning for kontroll av lus
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
EP1261331A4 (en) METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES
DE60028609D1 (de) Zusammensetzung zum entfernen von knitterfalten und entsprechendes behandlungsverfahren
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
ATE366573T1 (de) Neue behandlungsmethode
DK199801152A (da) Fremgangsmåde til opdræt af svin og svinesti til brug ved udøvelse af fremgangsmåden
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
DK1200446T3 (da) Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder
EP1173159A4 (en) COMPOSITION AND METHOD FOR TREATING COLIC

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application